Foley & Lardner LLP represented TCGX as co-lead investor. Alkeus Pharmaceuticals closed its $150 million Series B financing for Alkeus Pharmaceuticals. TCGX was joined by Bain…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now